Industry Groups Oppose 25% China Tariffs Still In Play On High-End Medical Equipment, Hospital Products
Executive Summary
Industry groups expressed strong opposition at the end of June to US-planned 25% tariffs on China goods – including billions of dollars in medtech and hospital supplies – by the US Trade Representative’s Office, despite ongoing talks between President Trump and Chinese President Xi Jinping to deal with US-China trade tensions.
You may also be interested in...
Advanced Imaging Companies Lobby Lawmakers On Device Servicing, Reimbursement Among Other Issues
Advanced imaging companies spent hundreds of thousands of dollars in Q1 2020 lobbying Congress on issues as diverse as the national COVID-19 response and cybersecurity issues but are most interested in resolving device servicing and remanufacturing problems.
US Trade Representative Removes Host Of Devices, Parts From China Tariff List
The US Trade Representative’s Office has agreed to remove a group of medtech products and components from its list of those imported from China that initially would be tariffed at 25%, making its exclusion-from-tariffs decision retroactive one year, and extending the exclusion to 9 July 2020.
US Starts Imposing China Medtech Tariffs, But Offers Path To Product Exclusions
Although the 25% tariffs initiated July 6 by the US Trade Representative will impact about $836m worth of medical technology entering the US from China, the administration late last week offered a process for gaining exclusions for specific products. AdvaMed members are “looking into” the process, the group said, and Medical Imaging and Technology Alliance members have already started to try to use it.